Clinical Trials Logo
  1. Home
  2. Myocardial Infarction, Acute
  3. NCT06038994
  4. Details
NCT06038994 Clinical Trial

Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction

Myocardial Infarction, Acute Clinical Trial

Official title:
Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06038994
Other study ID # 20230901
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2023
Est. completion date April 30, 2025

Study information
Verified date September 2023
Source Nanjing Medical University
Contact Jin Geng, MD.
Phone +86-17753124846
Email gj885258@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the prognostic value of surem TRAF3IP2 levels in patients with acute myocardial infarction

Description:

Previous study had concluded that TRAF3IP2 plays a causal role in atherosclerotic plaque development and vulnerability in mice. However, no human data was available. In the present study, patients diagnosed with acute myocardial infarction who receive coronary angiography will be enrolled. Their surem TRAF3IP2 levels will be tested using ELASA. The association of surem TRAF3IP2 levels with the major adverse cardiac events will be evaluated.

Recruitment information / eligibility
Status Recruiting
Enrollment 200
Est. completion date April 30, 2025
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: 1. Patients with acute myocardial infarction 2. patients received coronary angiography 3. invasive management within 72 h of hospital admission Exclusion Criteria: 1. NYHA III-IV 2. malignant tumor 3. acute infection 4. thyroid dysfunction 5. Life expectancy of b1 y 6. Unsuitable for PCI

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No intervention
This is an obvertional study, and there is no intervention.

Locations
Country Name City State
China Huai'an First People's Hospital Huai'an Jiangsu

Sponsors (1)
Lead Sponsor Collaborator
Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary MACEs (major adverse cardiac events) MACEs were defined as a composite of cardiac death, hospitalization for myocardial infarction or heart failure 1 year
Secondary cardiac death and death due to cardiac reasons, such as myocardial infarction or heart failure 1 year
Secondary hospitalization for myocardial infarction or heart failure hospitalization for myocardial infarction or heart failure 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05759078 - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Phase 4
Completed NCT06408636 - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Completed NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03317691 - The ALERT-Pilot Study N/A
Active, not recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT03957005 - Cardiovascular Risk Assessment Model in Patients With MI
Enrolling by invitation NCT05955950 - Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction N/A
Active, not recruiting NCT06141252 - Benefit of Hypothermia in OHCA Complicating AMI N/A
Not yet recruiting NCT04560023 - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction N/A
Recruiting NCT03809689 - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET N/A
Completed NCT05118009 - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) N/A
Active, not recruiting NCT04753749 - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy N/A
Completed NCT04769219 - Secondary Prevention Education After Acute Myocardial Infarction N/A
Active, not recruiting NCT05350969 - Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction Phase 2
Recruiting NCT05999110 - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) N/A
Completed NCT04167904 - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting NCT04989777 - IABP In AMI Patients With SCAI-B Study N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3
Recruiting NCT03600259 - Tianjin Inpatient Acute Myocardial Infarction Registry